T Lymphoblastic Lymphoma — Trials

T Lymphoblastic Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

26 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 11
Recruiting: 5
Ph III recruiting: 0
Growth YoY: —
Industry share: 18%
Top sponsor: Institute of Hematology & Blood Diseases Hospital, China
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07476027	Efficacy and Safety of CD7 CAR-T in Newly Diagnosed High-Risk T-LBL/ALL	not yet recruiting	Early Phase 1	10	Institute of Hematology & Blood Diseases Hospital, ChinaOTHER	0	Mar 17, 2026	clinicaltrials
NCT06633341	Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphoma	recruiting	Early Phase 1	30	Zhejiang UniversityOTHER	1	Oct 9, 2024	clinicaltrials